Is Synopsys (SNPS) Still Fairly Priced After Recent Share Price Weakness?

• If you are wondering whether Synopsys at around US$464.85 is priced for opportunity or already reflects high expectations, the key is to understand what different valuation tools actually say about the stock.
• Over shorter periods the picture has been mixed, with the share price down about 2.3% over the last week, down 7.8% over the last month, down 3.2% year to date, and down 4.4% over the last year. The 3 year and 5 year returns sit at 5.9% and 76.7% respectively.
• Recent coverage of Synopsys has focused on its role in electronic design automation and its position within the broader software sector, giving investors more context for how the stock trades against peers and sector sentiment. Commentary has also highlighted how the market treats Synopsys as a key player within chip design and software related themes, which can influence how quickly sentiment shifts when expectations change.
• Right now, Synopsys only clears 1 out of 6 valuation checks, giving it a value score of 1/6. The next step is to look at how different approaches like DCF, multiples and peer comparisons frame that result, and then consider an even broader framework for thinking about value at the end of this article.

Synopsys scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Synopsys Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a stock could be worth by projecting the company’s future cash flows and discounting them back to today’s value using a required rate of return.

For Synopsys, the model used is a 2 Stage Free Cash Flow to Equity framework. The company’s latest twelve month free cash flow is about $2.59b. Based on analyst inputs for the next few years and then extended projections by Simply Wall St, free cash flow is estimated to reach $4.93b by 2030, with a series of yearly projections between 2026 and 2035 that are each discounted back to today in the model.

When these projected and discounted cash flows are added up, the DCF model arrives at an estimated intrinsic value of about $460.37 per share. Compared with the current share price of around $464.85, the implied DCF result suggests the stock is about 1.0% overvalued, which is a very small gap.

Result: ABOUT RIGHT

Synopsys is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Synopsys.

Approach 2: Synopsys Price vs Earnings

For profitable companies, the P/E ratio is a useful shortcut because it connects what you pay for each share with the earnings that support that price. It is a simple way to see how much the market is willing to pay for each dollar of profit.

What counts as a normal or fair P/E depends a lot on growth expectations and risk. Higher expected earnings growth or lower perceived risk can justify a higher P/E, while slower growth or higher risk usually points to a lower one.

Synopsys currently trades on a P/E of about 115.1x. That sits well above the Software industry average of around 28.4x and also above the selected peer group average of about 38.4x. Simply Wall St’s Fair Ratio for Synopsys is 52.7x, which is a proprietary estimate of the P/E that might be reasonable given factors such as earnings growth, profit margins, industry, market cap and specific risk profile.

This Fair Ratio can be more informative than a simple peer or industry comparison because it adjusts for company specific traits instead of assuming all stocks deserve the same multiple. On this basis, Synopsys trades above the Fair Ratio, which points to the stock appearing overvalued on a P/E basis.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 21 top founder-led companies.

Upgrade Your Decision Making: Choose your Synopsys Narrative

Earlier it was mentioned that there is an even better way to understand valuation. That is where Narratives come in, letting you connect your view of Synopsys' story to concrete forecasts for revenue, earnings and margins, then to a fair value that you can easily compare with the current share price using Simply Wall St's Community Narratives. These update as news or earnings land. For example, one investor might build a Narrative that lines up with the higher analyst fair value around US$650.00 because they focus on Ansys integration and SaaS potential. Another might lean toward the lower US$403.85 view if they are more cautious about China, IP growth and execution risk. Both can see on the platform whether their chosen fair value points to Synopsys looking expensive or cheap at today's price.

Do you think there's more to the story for Synopsys? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com